EGF Theramed Health Corp. 最近的每股盈餘為 $,{eisBeating} $ 的預期。
EGF Theramed Health Corp. EVAHF 上一季度的收入表現如何?
EGF Theramed Health Corp. 上一季度的收入為 $
EGF Theramed Health Corp. 的收入預期是多少?
根據 位華爾街分析師的預測,EGF Theramed Health Corp. 的收入預期範圍從 $ 到 $
EGF Theramed Health Corp. 的盈利品質評分是多少?
EGF Theramed Health Corp. 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
EGF Theramed Health Corp. 何時發布財報?
EGF Theramed Health Corp. 的下一份財報預計在 發布
EGF Theramed Health Corp. 的預期收益是多少?
根據華爾街分析師的預測,EGF Theramed Health Corp. 的預期收益為 $
EGF Theramed Health Corp. 是否超出收益預期?
EGF Theramed Health Corp. 最近的收益為 $, 預期。
關鍵數據
前收市價
$0.057
開盤價
$0.057
當日範圍
$0.057 - $0.057
52週區間
$0.026 - $0.094
交易量
400
平均成交量
34
股息收益率
--
每股盈餘 (TTM)
-0.21
市值
$662.1K
什麼是 EGF THERAMED HEALTH CORP.?
EGF Theramed Health Corp. is a consumer technology company, which engages in the provision of biomedical online services for monitoring and treating common health problems. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-06-20. The firm is focused on the psilocybin space, looking at methods of improving delivery systems for the compound. The firm explores many other medical areas, including weight loss, skin care and heart disease. Its portfolio includes Pharmadelic Labs and Green Parrot Labs. Pharmadelic Labs is a biotech company focusing on improving and patenting engineering processes for the biosynthesis of compounds - primarily psilocybin, the psychoactive component of magic mushrooms. Green Parrot Labs is a Caribbean-based company focusing on research into psilocybin and establishing health centers dealing with treatment-resistant conditions. The firm is also actively exploring opportunities in all medical areas in domestic and international markets.